{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:30:31Z","timestamp":1765269031603,"version":"3.44.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LZ24H160001"],"award-info":[{"award-number":["LZ24H160001"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Alveolar rhabdomyosarcoma (ARMS) is a rare and highly aggressive malignant soft tissue tumor. ARMS is associated with a poor prognosis, especially in adults, occurring in the uterine cervix infrequently. To date, only 6 cases have been reported in the literature. We discuss the challenges in diagnosing and managing cervical ARMS and highlights the need for ongoing research into optimal treatment strategies for this malignancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 51-year-old female was diagnosed with advanced-stage ARMS. Positron emission tomography and computed tomography scans indicated a high metabolism mass in the uterus region, along with multiple lymph nodes enlargement in the pelvic, para-aorta and mediastinal regions. Cervical biopsy and segmental curettage revealed a small cell malignant tumor with poor differentiation. Histological and immunohistochemical examination confirmed ARMS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The final diagnosis was cervical ARMS, staged IV according to the Intergroup Rhabdomyosarcoma Studies Group based on the imaging and histology results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient underwent radical hysterectomy, bilateral salpingo-oophorectomy, pelvic lymphadenectomy, and para-aortic lymphadenectomy. Postoperatively, the patient received a series of chemotherapy regimens including VAC<jats:sup>\u2020<\/jats:sup> (vincristine, epirubicin, cyclophosphamide), EP (etoposide and cisplatin), VIP (etoposide, ifosfamide, cisplatin), gemcitabine and bevacizumab, gemcitabine and docetaxel, pertuzumab and lenvatinib and radiotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>ARMS has low incidence with unique clinical pathological characteristics. The biological behavior is more aggressive and the prognosis is worse in ARMS. Further research is necessary to refine treatment protocols and improve survival rates for this aggressive tumor.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043675","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:01:05Z","timestamp":1754089265000},"page":"e43675","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Alveolar rhabdomyosarcoma of cervix: A case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiuli","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology, Women\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2377-0775","authenticated-orcid":false,"given":"Junfen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Women\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/cam4.1374","article-title":"Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study.","volume":"7","author":"Bompas","year":"2018","journal-title":"Cancer Med"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","article-title":"Rhabdomyosarcoma.","volume":"5","author":"Skapek","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/jcm10092028","article-title":"Pediatric rhabdomyosarcoma: epidemiology and genetic susceptibility.","volume":"10","author":"Martin-Giacalone","year":"2021","journal-title":"J Clin Med"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"670","DOI":"10.31925\/farmacia.2023.4.2","article-title":"Pharmacological properties of Spirulina species: hepatoprotective, antioxidant and anticancer effects.","volume":"71","author":"Al-Hussaniy","year":"2023","journal-title":"Farmacia"},{"key":"R5-20250918","first-page":"196","article-title":"Alveolar rhabdomyosarcoma originating from the uterine cervix.","volume":"32","author":"Cakar","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"R6-20250918","first-page":"167","article-title":"Advanced alveolar rhabdomyosarcoma of the uterus: a case report.","volume":"13","author":"Odoi","year":"2009","journal-title":"Afr J Reprod Health"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ygyno.2004.11.009","article-title":"A case report of rhabdomyosarcoma of the uterus associated with uterine inversion.","volume":"96","author":"Case","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0090-8258(03)00252-X","article-title":"Alveolar rhabdomyosarcoma of the cervix.","volume":"91","author":"Ng","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PGP.0b013e31816085ce","article-title":"Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues.","volume":"27","author":"Rivasi","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1097-0142(19950915)76:6<1073::AID-CNCR2820760624>3.0.CO;2-L","article-title":"Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study.","volume":"76","author":"Newton","year":"1995","journal-title":"Cancer"},{"key":"R11-20250918","first-page":"627","article-title":"Effects of Mdm2 inhibitors on cellular viability of breast cancer cell lines HP100, MCF7.","volume":"125","author":"Al-Hussaniy","year":"2024","journal-title":"Bratisl Lek Listy"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"e28832","DOI":"10.1002\/pbc.28832","article-title":"Alveolar rhabdomyosarcoma with regional nodal involvement: results of a combined analysis from two cooperative groups.","volume":"68","author":"Gallego","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/1097-0142(19940115)73:2<476::AID-CNCR2820730237>3.0.CO;2-N","article-title":"Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current management.","volume":"73","author":"Hughes","year":"1994","journal-title":"Cancer"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.canrad.2007.05.005","article-title":"Paratesticular pleomorphic rhabdomyosarcoma in an adult: diagnosis and management.","volume":"11","author":"Kourda","year":"2007","journal-title":"Cancer Radiother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:00:34Z","timestamp":1758232834000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":14,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043675","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}